Summary
Definition
History and exam
Key diagnostic factors
- history of Helicobacter pylori gastritis
- history of autoimmune disorder
- age >60 years
- dyspepsia
- epigastric discomfort
- skin lesions
- red eye ± photophobia
- conjunctival fornix mass
- painless proptosis, motility disturbances of the eye, diplopia, ptosis, decreased vision
Other diagnostic factors
- abdominal pain, nausea, diarrhea, malabsorption, vomiting
- GI bleeding, perforation, and obstruction
- fever
- night sweats
- weight loss
- shortness of breath, hemoptysis, cough
- salivary gland swelling
- thyroid swelling
- esophageal/tracheal obstruction (shortness of breath, dysphagia, tracheal deviation)
- breast lump
- focal neurologic deficits
- lymphadenopathy
Risk factors
- Helicobacter pylori infection
- age >60 years
- autoimmune disease
- Chlamydia psittaci infection
- Campylobacter jejuni infection
- Borrelia burgdorferi infection
- hepatitis C virus infection
- hepatitis B virus infection
- HIV infection
- achromobacter xylosoxidans infection
Diagnostic tests
1st tests to order
- CBC with differential
- blood smear
- comprehensive metabolic panel (including LFTs)
- serum lactate dehydrogenase (LDH)
- serum beta-2 microglobulin
- upper GI endoscopy
- biopsy of affected site
- immunophenotyping
- H pylori (histologic testing)
- CT scan
Pruebas diagnósticas que deben considerarse
- H pylori (stool antigen test)
- H pylori (urea breath test)
- H pylori (serology test)
- PCR testing for infectious agents
- bone marrow biopsy with aspirate
- genetic studies
- immunoglobulin gene rearrangement studies
- MYD88 mutation testing
- serum protein electrophoresis
- 18F-fluorodeoxyglucose (FDG) PET/CT scan
- endoscopic ultrasound of the stomach
- lower GI endoscopy
- MRI orbit, brain
- mammography
- breast ultrasound
- MRI breast
- thyroid ultrasound
- bronchoscopy
- hepatitis C serology
- hepatitis B serology
- HIV serology
- multigated acquisition (MUGA) scan
- echocardiography
Algoritmo de tratamiento
localized gastric MALT lymphoma: Helicobacter pylori-positive and t(11;18)-negative (or unknown)
localized gastric MALT lymphoma: Helicobacter pylori-negative, or Helicobacter pylori-positive and t(11;18)-positive
advanced gastric MALT lymphoma
localized nongastric MALT lymphoma
advanced nongastric MALT lymphoma
high-grade histologic transformation
Colaboradores
Autores
Christopher McNamara, MBBS (Hons), FRACP, FRCPA, FRCPath
Consultant Haematologist
Royal Free Hospital
London
UK
Divulgaciones
CM declares that he has no competing interests.
Agradecimientos
Dr Christopher McNamara wishes to gratefully acknowledge Dr Rahul Joshi, a previous contributor to this topic. RJ declared that he had no competing interests. Unfortunately, we have since been made aware that Dr Rahul Joshi is deceased.
Revisores por pares
Markus Raderer, MD
Professor of Medicine
Department of Internal Medicine I
Division of Oncology
Medical University Vienna
Austria
Divulgaciones
MR is an author of a number of references cited in this topic.
Alan Lichtin, MD
Staff Hematologist
Cleveland Clinic Taussig Cancer Center
Cleveland
OH
Divulgaciones
AL declares that he has no competing interests.
Ian Chau, MD
Consultant Medical Oncologist
Royal Marsden Hospital
Sutton
UK
Divulgaciones
IC has been reimbursed by Roche Products, the manufacturer of rituximab, for attending several conferences. IC has also served on advisory boards and received honorarium for giving presentations for Roche Products. IC has received research funding from Novartis to conduct academic studies in the treatment of colorectal cancer.
Agradecimiento de los revisores por pares
Los temas de BMJ Best Practice se actualizan de forma continua de acuerdo con los desarrollos en la evidencia y en las guías. Los revisores por pares listados aquí han revisado el contenido al menos una vez durante la historia del tema.
Divulgaciones
Las afiliaciones y divulgaciones de los revisores por pares se refieren al momento de la revisión.
Referencias
Artículos principales
Zucca E, Arcaini L, Buske C, et al. Marginal zone lymphomas: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2020 Jan;31(1):17-29.Texto completo Resumen
Walewska R, Eyre TA, Barrington S, et al. Guideline for the diagnosis and management of marginal zone lymphomas: a British Society of Haematology guideline. Br J Haematol. 2024 Jan;204(1):86-107.Texto completo Resumen
National Comprehensive Cancer Network. NCCN clinical practice guidelines in oncology: B-cell lymphomas [internet publication].Texto completo
Artículos de referencia
Una lista completa de las fuentes a las que se hace referencia en este tema está disponible para los usuarios con acceso a todo BMJ Best Practice.

Diferenciales
- Mantle cell lymphoma
- Chronic lymphocytic leukemia/small lymphocytic lymphoma
- Follicular lymphoma
Más DiferencialesGuías de práctica clínica
- NCCN clinical practice guidelines in oncology: B-cell lymphomas
- Guideline for the diagnosis and management of marginal zone lymphomas
Más Guías de práctica clínicaFolletos para el paciente
Non-Hodgkin lymphoma
Más Folletos para el pacienteInicie sesión o suscríbase para acceder a todo el BMJ Best Practice
El uso de este contenido está sujeto a nuestra cláusula de exención de responsabilidad
